BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/22/2017 8:56:37 AM | Browse: 902 | Download: 2492
 |
Received |
|
2017-02-13 13:49 |
 |
Peer-Review Started |
|
2017-02-15 09:03 |
 |
To Make the First Decision |
|
2017-03-27 12:15 |
 |
Return for Revision |
|
2017-03-27 16:37 |
 |
Revised |
|
2017-07-06 21:14 |
 |
Second Decision |
|
2017-07-18 09:31 |
 |
Accepted by Journal Editor-in-Chief |
|
2017-07-20 11:09 |
 |
Accepted by Executive Editor-in-Chief |
|
2017-07-24 05:11 |
 |
Articles in Press |
|
2017-07-24 05:11 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2017-08-18 07:54 |
 |
Publish the Manuscript Online |
|
2017-08-22 07:27 |
ISSN |
2220-3230 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Transplantation |
Manuscript Type |
Observational Study |
Article Title |
Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
|
Manuscript Source |
Invited Manuscript |
All Author List |
Moussab Damlaj, Samer Ghazi, Walid Mashaqbeh, Gamal Gmati, Hend Salama, Khadega A Abuelgasim, Mushtaq Rather, Ali Hajeer, Mohsen Al-Zahrani, Abdul-Rahman Jazieh, Ayman Hejazi and Ahmad Al Askar |
Funding Agency and Grant Number |
|
Corresponding Author |
Moussab Damlaj, FACP, FRCP (C), MD, Division of Hematology and HSCT, Department of Oncology, King Abdulaziz Medical City, P.O. Box 22490, Riyadh 11426, Saudi Arabia. damlajmo@ngha.med.sa |
Key Words |
Acute leukemia; Allogeneic transplant; Absolute lymphocyte count |
Core Tip |
Disease relapse remains the most common cause of treatment failure after allogeneic hematopoietic stem cell transplantation for acute leukemia. Previous studies have identified that early lymphocyte recovery can be a surrogate of graft vs leukemia effect hence identifying high risk patients for relapse. However, published reports are heterogeneous with regards to timeline and magnitude of lymphocyte recovery. Using receiver operator characteristics with area under the curve, we identified that absolute lymphocyte count > 0.3 × 109/L at day 14 is associated with half the relapse risk which was statistically significant at the multivariable analysis. There was a trend towards improved progression free survival and overall survival for patients with early lymphocyte recovery. In conclusion, we observed that lymphocyte recovery is an independent predictor of relapse in allogeneic transplant recipients for acute leukemia. This would help identify high risk patients who may benefit from maintenance strategies post-transplant. |
Publish Date |
2017-08-22 07:27 |
Citation |
Damlaj M, Ghazi S, Mashaqbeh W, Gmati G, Salama H, Abuelgasim KA, Rather M, Hajeer A, Al-Zahrani M, Jazieh AR, Hejazi A, Al Askar A. Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia. World J Transplant 2017; 7(4): 235-242 |
URL |
http://www.wjgnet.com/2220-3230/full/v7/i4/235.htm |
DOI |
http://dx.doi.org/10.5500/wjt.v7.i4.235 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345